CNE000001808
CNE000001808
TIANJIN PHARMACEUTICAL DA REN T
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 4.917.335.979 | 7.306.736.059 | 32.7% |
| Cost of Revenue | 1.277.410.418 | 3.786.015.011 | 66.3% |
| Gross Profit | 3.639.925.561 | 3.520.721.047 | 3.4% |
| 2.668.774.802 | 2.665.510.824 | 0.1% | |
| Operating Income | 971.150.759 | 855.210.224 | 13.6% |
| Pretax Income | 2.487.451.831 | 2.578.782.876 | 3.5% |
| Net Income Common Stockholders | 2.131.021.537 | 2.229.334.236 | 4.4% |
| -- | -- | -- | |
| -- | -- | -- |